UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree.

The formation of mucin-type O-glycans is initiated by an evolutionarily conserved family of enzymes, the UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). The human genome encodes 20 transferases; 17 of which have been characterized functionally. The complexity of the GalNAc-T family reflects the differential patterns of expression among the individual enzyme isoforms and the unique substrate specificities which are required to form the dense arrays of glycans that are essential for mucin function. We report the expression patterns and enzymatic activity of the remaining three members of the family and the further characterization of a recently reported isoform, GalNAc-T17. One isoform, GalNAcT-16 that is most homologous to GalNAc-T14, is widely expressed (abundantly in the heart) and has robust polypeptide transferase activity. The second isoform GalNAc-T18, most similar to GalNAc-T8, -T9 and -T19, completes a discrete subfamily of GalNAc-Ts. It is widely expressed and has low, albeit detectable, activity. The final isoform, GalNAc-T20, is most homologous to GalNAc-T11 but lacks a lectin domain and has no detectable transferase activity with the panel of substrates tested. We have also identified and characterized enzymatically active splice variants of GalNAc-T13 that differ in the sequence of their lectin domain. The variants differ in their affinities for glycopeptide substrates. Our findings provide a comprehensive view of the complexities of mucin-type O-glycan formation and provide insight into the underlying mechanisms employed to heavily decorate mucins and mucin-like domains with carbohydrate.

[1]  P. Roepstorff,et al.  UDP-N-acetyl-α-D-galactosamine:polypeptide N-Acetylgalactosaminyltransferase , 1995, The Journal of Biological Chemistry.

[2]  Å. Elhammer,et al.  Identification of two cysteine residues involved in the binding of UDP-GalNAc to UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1). , 2002, European journal of biochemistry.

[3]  Lawrence A Tabak,et al.  All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. , 2003, Glycobiology.

[4]  T. Gerken,et al.  Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc transferase ortholog pairs. , 2008, Glycobiology.

[5]  G. Hummer,et al.  Substrate-induced conformational changes and dynamics of UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase-2. , 2007, Journal of molecular biology.

[6]  L. Tabak,et al.  Glycopeptide-preferring Polypeptide GalNAc Transferase 10 (ppGalNAc T10), Involved in Mucin-type O-Glycosylation, Has a Unique GalNAc-O-Ser/Thr-binding Site in Its Catalytic Domain Not Found in ppGalNAc T1 or T2* , 2009, The Journal of Biological Chemistry.

[7]  M. Konishi,et al.  Brain-specific expression of a novel human UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T9). , 2000, Biochimica et biophysica acta.

[8]  L. Tabak,et al.  Cloning and Characterization of a Ninth Member of the UDP-GalNAc:Polypeptide N-Acetylgalactosaminyltransferase Family, ppGaNTase-T9* , 2001, The Journal of Biological Chemistry.

[9]  L. Tabak,et al.  Deconvoluting the functions of polypeptide N-alpha-acetylgalactosaminyltransferase family members by glycopeptide substrate profiling. , 2004, Chemistry & biology.

[10]  E. Berger,et al.  Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. , 1998, Journal of cell science.

[11]  G. Rubin,et al.  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Morishita,et al.  Cloning and expression of a brain-specific putative UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase gene. , 2005, Biological & pharmaceutical bulletin.

[13]  K. Carraway,et al.  Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways. , 2007, Current topics in developmental biology.

[14]  J. Gagnon,et al.  Glycopeptide N-acetylgalactosaminyltransferase specificities for O-glycosylated sites on MUC5AC mucin motif peptides. , 2001, The Biochemical journal.

[15]  Lawrence A Tabak,et al.  Dynamic Association between the Catalytic and Lectin Domains of Human UDP-GalNAc:Polypeptide α-N-Acetylgalactosaminyltransferase-2* , 2006, Journal of Biological Chemistry.

[16]  Lawrence A Tabak,et al.  Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. , 2012, Glycobiology.

[17]  J. Marth,et al.  Cloning and Characterization of a New Human UDP-N-Acetyl-α-d-galactosamine:PolypeptideN-Acetylgalactosaminyltransferase, Designated pp-GalNAc-T13, That Is Specifically Expressed in Neurons and Synthesizes GalNAc α-Serine/Threonine Antigen* , 2003, The Journal of Biological Chemistry.

[18]  L. Tabak,et al.  Characterization of a UDP-GalNAc:Polypeptide N-Acetylgalactosaminyltransferase That Displays Glycopeptide N-Acetylgalactosaminyltransferase Activity* , 1999, The Journal of Biological Chemistry.

[19]  M. Oelgeschläger,et al.  Regulation of TGF-β signalling by N-acetylgalactosaminyltransferase-like 1 , 2008, Development.

[20]  L. Tabak.  In defense of the oral cavity: structure, biosynthesis, and function of salivary mucins. , 1995, Annual review of physiology.

[21]  P. Singh,et al.  Cell surface-associated mucins in signal transduction. , 2006, Trends in cell biology.

[22]  K. Tachibana,et al.  Identification of a novel human UDP-GalNAc transferase with unique catalytic activity and expression profile. , 2010, Biochemical and biophysical research communications.

[23]  Hiromichi Sawaki,et al.  Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10). , 2006, Journal of molecular biology.

[24]  T. Meitinger,et al.  Molecular cloning of a novel human UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T8, and analysis as a candidate autosomal dominant hypophosphatemic rickets (ADHR) gene. , 2000, Gene.

[25]  R. Nussinov,et al.  Interdependence of backbone flexibility, residue conservation, and enzyme function: a case study on beta1,4-galactosyltransferase-I. , 2003, Biochemistry.

[26]  L. Tabak,et al.  The Crystal Structure of UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase-T1 , 2004 .

[27]  Lawrence A Tabak,et al.  Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase isoforms in murine tissues determined by real-time PCR: a new view of a large family. , 2003, Glycobiology.

[28]  L. Tabak,et al.  Biosynthesis of a low-molecular-mass rat submandibular gland mucin glycoprotein in COS7 cells. , 1997, Biochemical Journal.

[29]  L. Tabak,et al.  The Catalytic and Lectin Domains of UDP-GalNAc:Polypeptide α-N-Acetylgalactosaminyltransferase Function in Concert to Direct Glycosylation Site Selection* , 2008, Journal of Biological Chemistry.

[30]  V. Korolik,et al.  Mucins in the mucosal barrier to infection , 2008, Mucosal Immunology.

[31]  Wei Li,et al.  Characterization of ppGalNAc-T18, a member of the vertebrate-specific Y subfamily of UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases. , 2012, Glycobiology.

[32]  P. Cullen.  Signaling mucins: the new kids on the MAPK block. , 2007, Critical reviews in eukaryotic gene expression.

[33]  M. Pasumarthy,et al.  Site-specific Core 1 O-Glycosylation Pattern of the Porcine Submaxillary Gland Mucin Tandem Repeat , 1998, The Journal of Biological Chemistry.

[34]  J. Sheehan,et al.  Innate immunity and mucus structure and function. , 2008, Novartis Foundation symposium.

[35]  M. Hollingsworth,et al.  A novel human UDP‐N‐acetyl‐D‐galactosamine:polypeptide N‐acetylgalactosaminyltransferase, GalNAc‐T7, with specificity for partial GalNAc‐glycosylated acceptor substrates , 1999, FEBS letters.